JOHNSON DAVID LEE
Insider CIK 1733883 · CRBU Director · GBT Chief Commercial Officer · VERA Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics, Inc. | S Sale | 2026-02-23 | 2026-02-25 | 2,579 | $41.98 | $108.3K | 45,727 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2026-02-04 | 2026-02-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award | 2026-02-04 | 2026-02-06 | 20,000 | — | $0 | 48,306 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 53,800 | — | $0 | 53,800 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award | 2025-02-18 | 2025-02-20 | 26,900 | — | $0 | 26,900 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2024-07-01 | 2024-07-03 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 3,125 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 13,814 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 15,460 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 42,400 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 40,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 26,454 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 10,935 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 55,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 28,628 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 38,739 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 38,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 34,384 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2022-09-28 | 2022-10-06 | 22,000 | — | $0 | 34,384 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 2,763 | — | $0 | 13,814 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 2,208 | — | $0 | 15,460 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 2,208 | — | $0 | 58,487 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 2,763 | — | $0 | 56,279 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-09-01 | 2022-09-06 | 2,103 | $68.15 | $143.3K | 56,384 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2022-08-31 | 2022-09-06 | 365 | $25.37 | $9.3K | 53,516 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,645 | — | $0 | 10,935 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,125 | — | $0 | 3,125 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-08-01 | 2022-08-03 | 6,770 | — | $0 | 55,493 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-08-01 | 2022-08-03 | 2,342 | $32.40 | $75.9K | 53,151 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2022-05-18 | 2022-05-18 | 44,000 | — | $0 | 44,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-04-01 | 2022-04-05 | 4,375 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-04-01 | 2022-04-05 | 1,513 | $35.91 | $54.3K | 48,424 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-04-01 | 2022-04-05 | 4,375 | — | $0 | 49,937 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 17,668 | — | $0 | 17,668 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 17,668 | — | $0 | 17,668 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 28,628 | — | $0 | 28,628 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-03-01 | 2022-03-03 | 2,763 | — | $0 | 16,577 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-03-01 | 2022-03-03 | 956 | $29.87 | $28.6K | 45,562 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-03-01 | 2022-03-03 | 2,763 | — | $0 | 46,518 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2022-02-28 | 2022-03-03 | 472 | $25.37 | $12.0K | 43,755 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,125 | — | $0 | 6,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,645 | — | $0 | 14,580 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-02-01 | 2022-02-03 | 2,559 | $29.33 | $75.1K | 43,283 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-02-01 | 2022-02-03 | 6,770 | — | $0 | 45,842 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-10-01 | 2021-10-05 | 4,375 | — | $0 | 4,375 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-10-01 | 2021-10-05 | 2,170 | $26.25 | $57.0K | 39,072 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-10-01 | 2021-10-05 | 4,375 | — | $0 | 41,242 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-09-01 | 2021-09-03 | 2,762 | — | $0 | 19,340 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-09-01 | 2021-09-03 | 1,072 | $29.85 | $32.0K | 36,867 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-09-01 | 2021-09-03 | 2,762 | — | $0 | 37,939 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2021-08-31 | 2021-09-03 | 480 | $24.39 | $11.7K | 35,177 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,645 | — | $0 | 18,225 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,125 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 3,125 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 3,645 | — | $0 | 18,225 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-08-03 | 2,342 | $27.33 | $64.0K | 34,697 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-08-03 | 6,770 | — | $0 | 37,039 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-09-24 | 6,770 | — | $0 | 37,039 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-09-24 | 2,342 | $27.33 | $64.0K | 34,697 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-04-01 | 2021-04-02 | 4,375 | — | $0 | 8,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-04-01 | 2021-04-02 | 4,375 | — | $0 | 31,782 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-04-01 | 2021-04-02 | 1,513 | $42.62 | $64.5K | 30,269 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 22,102 | — | $0 | 22,102 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 38,739 | — | $0 | 38,739 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2021-02-28 | 2021-03-03 | 375 | $36.21 | $13.6K | 27,407 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,125 | — | $0 | 12,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,645 | — | $0 | 21,870 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-02-01 | 2021-02-03 | 6,770 | — | $0 | 29,490 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-02-01 | 2021-02-03 | 2,458 | $49.49 | $121.6K | 27,032 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-10-01 | 2020-10-05 | 4,375 | — | $0 | 13,125 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-10-01 | 2020-10-05 | 2,170 | $57.96 | $125.8K | 22,720 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-10-01 | 2020-10-05 | 4,375 | — | $0 | 24,890 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,125 | — | $0 | 15,625 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,645 | — | $0 | 25,515 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-08-01 | 2020-08-04 | 2,618 | $67.48 | $176.7K | 20,515 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-08-01 | 2020-08-04 | 6,770 | — | $0 | 23,133 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2020-07-31 | 2020-08-04 | 316 | $36.68 | $11.6K | 16,363 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-01 | 2020-06-03 | 42,400 | — | $0 | 42,400 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-04-01 | 2020-04-03 | 4,375 | — | $0 | 17,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-04-01 | 2020-04-03 | 4,375 | — | $0 | 17,560 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-04-01 | 2020-04-03 | 1,513 | $48.73 | $73.7K | 16,047 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 38,500 | — | $0 | 38,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 29,160 | — | $0 | 29,160 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 3,125 | — | $0 | 18,750 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-02-01 | 2020-02-04 | 1,167 | $65.26 | $76.2K | 13,185 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-02-01 | 2020-02-04 | 3,125 | — | $0 | 14,352 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2020-01-31 | 2020-02-04 | 310 | $36.68 | $11.4K | 11,227 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-10-01 | 2019-10-02 | 4,375 | — | $0 | 21,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-10-01 | 2019-10-02 | 4,375 | — | $0 | 12,454 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-10-01 | 2019-10-02 | 1,537 | $46.99 | $72.2K | 10,917 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 3,125 | — | $0 | 21,875 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-08-01 | 2019-08-05 | 1,081 | $54.25 | $58.6K | 8,079 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-08-01 | 2019-08-05 | 3,125 | — | $0 | 9,160 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2019-07-31 | 2019-08-05 | 311 | $36.68 | $11.4K | 6,035 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-04-01 | 2019-04-02 | 8,750 | — | $0 | 26,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-04-01 | 2019-04-02 | 8,750 | — | $0 | 8,750 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-04-01 | 2019-04-02 | 3,026 | $52.90 | $160.1K | 5,724 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 40,000 | — | $0 | 40,000 | SEC↗ |